The United Nations recommends that China institute new food safety laws in order to restore confidence in its food supply. Specifically, the UN calls for revising the country’s basic hygiene law to include the entire food chain. The UN paper also advocates the establishment of one government agency to replace the six agencies that current […]
China is the best outsourcing destination for pharmaceutical R&D and manufacturing in Asia, according to an analysis by PricewaterhouseCoopers (PwC). The results are based on an analysis of cost, risk and market opportunity, which were assigned the respective weights of 33%, 37% and 30%. The other top 5 destinations are India, Korea, Taiwan and Japan. […]
French biotechnology companies have 73 products in early-stage development and 98 drugs in clinical development, according to France Biotech. Ten drugs are awaiting market approval and four are on the market. Despite economic conditions and a weak IPO market, France Biotech expects French biotech firms to be able to obtain funding through alliances or mergers […]
R&D spending in Hungary increased 3.3% last year to HUF 245.7 billion ($1,483 million) to make up 0.97% of GDP, down from 1% in 2006. Private funding accounted for 44% of R&D expenditures, the government represented 44%, while foreign funding made up 11% and nonprofits represented 1%. Basic and applied research accounted for 16% of […]
The addition of the chemical melamine to Chinese dairy products has caused more than 10 infant deaths worldwide and over 50,000 children in China to be hospitalized. Melamine in itself is not harmful, but when levels are high enough, it can cause crystals to form in the liver, leading to renal failure. This scandal comes […]
The Federal Ministry for Education and Research (BMBF) has selected three public-private consortia to receive €100 million ($142.9 million) to advance the efficiency of pharmaceutical research. The Max Planck Drug Discovery & Development Center will commercialize research from the Max Planck Institutes and other research institutes. The Neuroallianz consortium consists of 12 partners, including Schwarz […]
This month, Sweden announced the largest R&D investment in its history. The Swedish government’s 2009 budget commits SEK 2.4 billion ($364 million) in 2009 to research funding. Such funding will reach SEK 5 billion in 2012. The funding includes the elimination of the value added tax on education. Medicine, technology and the climate will receive […]
New regulations designed to simplify pesticide residue laws in the EU took effect on September 1. The rules harmonize the maximum residue levels (MRLs) for pesticides and cover approximately 1,100 pesticides used both in the EU and elsewhere. MRLs are listed for 315 agricultural products, including processed products. In addition, a new publicly available database […]
According to South Africa’s “National Survey of Research and Experimental Development: the country’s gross domestic expenditure on R&D totaled ZAR 16,520.6 million ($1.95 billion), 0.95% of GDP, in 2006-2007 for a nominal annual increase of 16.8%. Engineering sciences, natural sciences, and medical and health sciences comprised 20.9%, 20.3% and 15.1% of R&D, respectively. Applied sciences […]
India’s Central Drugs Standard Control Organization (CDSCO) is preparing plans to enable foreign drug companies to conduct phase I clinical trials in the country, according to a government official. Currently, only Indian companies can conduct phase 0 and I trials domestically. KPMG estimates that India’s clinical research market was worth $200 million in 2007 and […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
